{
    "2019-10-31": [
        [
            {
                "time": "2023-10-25",
                "original_text": "United Therapeutics (UTHR) Q3 Earnings & Sales Top, Stock Up",
                "features": {
                    "keywords": [
                        "Q3 Earnings",
                        "Sales Top",
                        "Stock Up"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-25",
                "original_text": "Sanofi (SNY) Q3 Earnings Beat, Vaccines/CHC Units Hurt Sales",
                "features": {
                    "keywords": [
                        "Q3 Earnings Beat",
                        "Vaccines/CHC Units",
                        "Hurt Sales"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-25",
                "original_text": "Dicerna ropes in Roche on gene-silencing deal worth up to $1.67B",
                "features": {
                    "keywords": [
                        "Dicerna",
                        "Roche",
                        "gene-silencing",
                        "deal",
                        "$1.67B"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}